5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      A double-blind comparison of zuclopenithixol tablets with placebo in the treatment of mentally handicapped in-patients with associated behavioural disorders

      ,
      Journal of Intellectual Disability Research
      Wiley-Blackwell

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references2

          • Record: found
          • Abstract: found
          • Article: not found

          Clopenthixol decanoate in schizophrenia.

          Clopenthixol decanoate was given to 20 chronic schizophrenic patients for 11 months in doses ranging from 100 mg initially up to 1000 mg 3-weekly subsequently, according to clinical response and the occurrence of adverse effects. A further 3 patients received the depot injections for periods of 6 to 9 months. Improvement in individual symptoms was rated on a 4-point scale. Unwanted effects were recorded on a checklist and routine biochemical and haematological tests were carried out at the beginning and end of the treatment period. There were highly significant improvements in the mean overall symptom score and in the 5 single symptom scores (hallucinations, delusions, depression, aggressive behaviour and non-aggressive behaviour disturbance). The 2 'negative' symptoms of apathy and social withdrawal showed improvement up to 16 weeks but not at 11 months. The incidence of depression was less at the end of the study than at the time fo entry. Three patients stopped the drug after the sixth month because of extrapyramidal symptoms (2) or drowsiness (1). Three others developed severe extra-pyramidal side-effects. Unwanted effects, though recorded in 70% of patients--drowsiness and extrapyramidal symptoms were the commonest--were for the most part trivial, and were fewer and less severe than they were on entry to the study. There was no evidence of toxicity. It was considered that on the basis of this experience the drug was an effective, safe antipsychotic agent, warranting more extensive clinical trial.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Classification of Side Effects in Psychopharmacology

              Bookmark

              Author and article information

              Journal
              Journal of Intellectual Disability Research
              Wiley-Blackwell
              09642633
              13652788
              December 1992
              June 2008
              : 36
              : 6
              : 541-549
              Article
              10.1111/j.1365-2788.1992.tb00572.x
              335733cf-68ea-4202-a4ef-327d9028ead5
              © 1992

              http://doi.wiley.com/10.1002/tdm_license_1.1

              History

              Comments

              Comment on this article